Localization of insulin-like growth factor (IGFBP)-3 in cultured porcine embryonic myogenic cells before and after TGF-β1 treatment

Domestic Animal Endocrinology

Volumn 33, Issue 4, 2007, Pages 422-429

  Xi, G ^a   Hathaway, M R ^a   White, M E ^a   Dayton, W R ^a  

^a UNIVERSITY OF MINNESOTA   (United States)

Author keywords

IGFBP 3; Localization; Muscle; Pig; TGF 1

Indexed keywords

RECOMBINANT PROTEIN; SOMATOMEDIN BINDING PROTEIN 3; TRANSFORMING GROWTH FACTOR BETA1;

ANIMAL; ARTICLE; CELL CULTURE; CELL DIFFERENTIATION; CELL DIVISION; CELL NUCLEUS; CHEMISTRY; CYTOPLASM; DRUG EFFECT; MUSCLE; PRENATAL DEVELOPMENT; SWINE; ULTRASTRUCTURE;

ANIMALS; CELL DIFFERENTIATION; CELL DIVISION; CELL NUCLEUS; CELLS, CULTURED; CYTOPLASM; INSULIN-LIKE GROWTH FACTOR BINDING PROTEIN 3; MUSCLES; RECOMBINANT PROTEINS; SWINE; TRANSFORMING GROWTH FACTOR BETA1;

SUIDAE; SUS;

EID: 34848906800     PISSN: 07397240     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.domaniend.2006.08.006     Document Type: Article

References (36)

1. Baxter R.C., Butt A.J., Schedlich L.J., and Martin J.L. Antiproliferative and pro-apoptotic activities of insulin-like growth factor-binding protein-3. Growth Horm IGF Res 10 Suppl. A (2000) S10-S11
2. Baxter R.C. Insulin-like growth factor (IGF)-binding proteins: interactions with IGFs and intrinsic bioactivities. Am J Physiol Endocrinol Metab 278 (2000) E967-E976
3. Cobb L.J., Salih D.A., Gonzalez I., Tripathi G., Carter E.J., Lovett F., et al. Partitioning of IGFBP-5 actions in myogenesis: IGF-independent anti-apoptotic function. J Cell Sci 117 (2004) 1737-1746
4. Hwa V., Oh Y., and Rosenfeld R.G. The insulin-like growth factor-binding protein (IGFBP) superfamily. Endocr Rev 20 (1999) 761-787
5. Johnson B.J., Halstead N., White M.E., Hathaway M.R., and Dayton W.R. Activation state of muscle satellite cells isolated from steers implanted with a combined trenbolone acetate and estradiol implant. J Anim Sci 76 (1998) 2779-2786
6. Kamanga-Sollo E., Pampusch M.S., Xi G., White M.E., Hathaway M.R., and Dayton W.R. IGF-I mRNA levels in bovine satellite cell cultures: Effects of fusion and anabolic steroid treatment. J Cell Physiol 201 (2004) 181-189
7. Yi Z., Hathaway M.R., Dayton W.R., and White M.E. Effects of growth factors on insulin-like growth factor binding protein (IGFBP) secretion by primary porcine satellite cell cultures. J Anim Sci 79 (2001) 2820-2826
8. Pampusch M.S., Kamanga-Sollo E., Loseth K.J., Hathaway M.R., Dayton W.R., and White M.E. Production of recombinant porcine IGF-binding protein-5 (IGFBP-5) and its effect on proliferation of porcine embryonic myoblast cultures (PEMC) in the presence and absence of IGF-I and Long-R3-IGF-I. J Endocrinol 185 (2005) 197-206
9. Xi G., Kamanga-Sollo E., Pampusch M.S., White M.E., Hathaway M.R., and Dayton W.R. Effect of recombinant porcine IGFBP-3 on IGF-I and Long-R3-IGF-I-stimulated proliferation and differentiation of L6 myogenic cells. J Cell Physiol 200 (2004) 387-394
10. Pampusch M.S., Kamanga-Sollo E., White M.E., Hathaway M.R., and Dayton W.R. Effect of recombinant porcine IGF-binding protein-3 on proliferation of embryonic porcine myogenic cell cultures in the presence and absence of IGF-I. J Endocrinol 176 (2003) 227-235
11. Johnson B.J., White M.E., Hathaway M.R., and Dayton W.R. Effect of differentiation on levels of insulin-like growth factor binding protein mRNAs in cultured porcine embryonic myogenic cells. Domest Anim Endocrinol 24 (2003) 81-93
12. Johnson B.J., White M.E., Hathaway M.R., and Dayton W.R. Decreased steady-state insulin-like growth factor binding protein-3 (IGFBP-3) mRNA level is associated with differentiation of cultured porcine myogenic cells. J Cell Physiol 179 (1999) 237-243
13. Kamanga-Sollo E., Pampusch M.S., White M.E., and Dayton W.R. Role of insulin-like growth factor binding protein (IGFBP)-3 in TGF-beta- and GDF-8 (myostatin)-induced suppression of proliferation in porcine embryonic myogenic cell cultures. J Cell Physiol 197 (2003) 225-231
14. Fanayan S., Firth S.M., Butt A.J., and Baxter R.C. Growth inhibition by insulin-like growth factor-binding protein-3 in T47D breast cancer cells requires transforming growth factor-beta (TGF-beta) and the type II TGF-beta receptor. J Biol Chem 275 (2000) 39146-39151
15. Oh Y., Gucev Z., Ng L., Muller H.L., and Rosenfeld R.G. Antiproliferative actions of insulin-like growth factor binding protein (IGFBP)-3 in human breast cancer cells. Prog Growth Factor Res 6 (1995) 503-512
16. Cohen P., Rajah R., Rosenbloom J., and Herrick D.J. IGFBP-3 mediates TGF-beta1-induced cell growth in human airway smooth muscle cells. Am J Physiol Lung Cell Mol Physiol 278 (2000) L545-L551
17. Kamanga-Sollo E., Pampusch M.S., White M.E., Hathaway M.R., and Dayton W.R. Insulin-like growth factor binding protein (IGFBP)-3 and IGFBP-5 mediate TGF-beta- and myostatin-induced suppression of proliferation in porcine embryonic myogenic cell cultures. Exp Cell Res 311 (2005) 167-176
18. Fanayan S., Firth S.M., and Baxter R.C. Signaling through the Smad pathway by insulin-like growth factor-binding protein-3 in breast cancer cells. Relationship to transforming growth factor-beta 1 signaling. J Biol Chem 277 (2002) 7255-7261
19. Kuemmerle J.F., Murthy K.S., and Bowers J.G. IGFBP-3 activates TGF-beta receptors and directly inhibits growth in human intestinal smooth muscle cells. Am J Physiol Gastrointest Liver Physiol 287 (2004) G795-G802
20. Jaques G., Noll K., Wegmann B., Witten S., Kogan E., Radulescu R.T., et al. Nuclear localization of insulin-like growth factor binding protein 3 in a lung cancer cell line. Endocrinology 138 (1997) 1767-1770
21. Schedlich L.J., Young T.F., Firth S.M., and Baxter R.C. Insulin-like growth factor-binding protein (IGFBP)-3 and IGFBP-5 share a common nuclear transport pathway in T47D human breast carcinoma cells. J Biol Chem 273 (1998) 18347-18352
22. Wraight C.J., Liepe I.J., White P.J., Hibbs A.R., and Werther G.A. Intranuclear localization of insulin-like growth factor binding protein- 3 (IGFBP-3) during cell division in human keratinocytes. J Invest Dermatol 111 (1998) 239-242
23. Liu B., Lee H.Y., Weinzimer S.A., Powell D.R., Clifford J.L., Kurie J.M., et al. Direct functional interactions between insulin-like growth factor-binding protein-3 and retinoid X receptor-alpha regulate transcriptional signaling and apoptosis. J Biol Chem 275 (2000) 33607-33613
24. Oufattole M., Lin S.W., Liu B., Mascarenhas D., Cohen P., and Rodgers B.D. Ribonucleic acid polymerase II binding subunit 3 (Rpb3), a potential nuclear target of insulin-like growth factor binding protein-3. Endocrinology 147 (2006) 2138-2146
25. Lee K.W., Liu B., Ma L., Li H., Bang P., Koeffler H.P., et al. Cellular internalization of insulin-like growth factor binding protein-3: distinct endocytic pathways facilitate re-uptake and nuclear localization. J Biol Chem 279 (2004) 469-476
26. Grimberg A., and Cohen P. Role of insulin-like growth factors and their binding proteins in growth control and carcinogenesis. J Cell Physiol 183 (2000) 1-9
27. Hembree J.R., Pampusch M.S., Yang F., Causey J.L., Hathaway M.R., and Dayton W.R. Cultured porcine myogenic cells produce insulin-like growth factor binding protein-3 (IGFBP-3) and transforming growth factor beta-1 stimulates IGFBP-3 production. J Anim Sci 74 (1996) 1530-1540
28. Hembree J.R., Hathaway M.R., and Dayton W.R. Isolation and culture of porcine myogenic cells and the effect of insulin, IGF-1 and sera on protein turnover in porcine myotube cultures. J Anim Sci 69 (1991) 3241-3250
29. Pampusch M.S., Hembree J.R., Hathaway M.R., and Dayton W.R. Effect of transforming growth factor beta on proliferation of L6 and embryonic porcine myogenic cells. J Cell Physiol 143 (1990) 524-528
30. Yang F., Johnson B.J., White M.E., Hathaway M.R., and Dayton W.R. Effect of insulin-like growth factor (IGF)-I and Des (1-3) IGF-I on the level of IGF binding protein-3 and IGF binding protein-3 mRNA in cultured porcine embryonic muscle cells. J Cell Physiol 178 (1999) 227-234
31. Edmondson S.R., Thumiger S.P., Kaur P., Loh B., Koelmeyer R., Li A., et al. Insulin-like growth factor binding protein-3 (IGFBP-3) localizes to and modulates proliferative epidermal keratinocytes in vivo. Br J Dermatol 152 (2005) 225-230
32. Hampel B., Wagner M., Teis D., Zwerschke W., Huber L.A., and Jansen-Durr P. Apoptosis resistance of senescent human fibroblasts is correlated with the absence of nuclear IGFBP-3. Aging Cell 4 (2005) 325-330
33. Santer F.R., Bacher N., Moser B., Morandell D., Ressler S., Firth S.M., et al. Nuclear insulin-like growth factor binding protein-3 induces apoptosis and is targeted to ubiquitin/proteasome-dependent proteolysis. Cancer Res 66 (2006) 3024-3033
34. Xi G., Kamanga-Sollo E., Hathaway M.R., Dayton W.R., and White M.E. Effect of constitutive expression of porcine IGFBP-3 on proliferation and differentiation of L6 myogenic cells. Domest Anim Endocrinol 31 (2005) 35-51
35. Baxter R.C. Signalling pathways involved in antiproliferative effects of IGFBP-3: a review. Mol Pathol 54 (2001) 145-148
36. Kubler B., Draeger C., John H., Andag U., Scharf J.G., Forssmann W.G., et al. Isolation and characterization of circulating fragments of the insulin-like growth factor binding protein-3. FEBS Lett 518 (2002) 124-128